---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-290726"
form_type: "8-K"
ticker: null
cik: "0001851194"
company_name: "Ventyx Biosciences, Inc."
filed_at: "2023-12-07T23:59:59+00:00"
generated_at: "2026-06-07T16:25:14.092562+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Ventyx Biosciences reduces workforce by ~20%, expects $2.0M severance costs

## Summary
- Reduction in force impacts approximately 20% of the company's workforce.
- Estimated total severance and benefit expenses of $2.0 million.
- Additional charges may be incurred; details to follow in 2023 10-K.

## SEC filing metadata
- accession: 0001193125-23-290726
- form_type: 8-K
- cik: 0001851194
- company_name: Ventyx Biosciences, Inc.
- filed_at: 2023-12-07T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.05
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1851194/000119312523290726/0001193125-23-290726-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1851194/000119312523290726/d548412d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-290726
- JSON: https://secwatch.observer/filing/0001193125-23-290726.json
- Plain text: https://secwatch.observer/filing/0001193125-23-290726.txt

## Key facts
- Restructurings & Charges
  Ventyx Biosciences, Inc. announced a restructuring with charges of approximately $2.0 million (approximately 20% of the Company’s workforce).
  - Type: restructuring
  - Charge: approximately $2.0 million
  - Headcount: approximately 20% of the Company’s workforce
  source text: On December 5, 2023, Ventyx Biosciences, Inc. (the “Company”), committed to and implemented a reduction in force that impacted approximately 20% of the Company’s workforce. The Company expects to recognize approximately $2.0 million in total expenses for severance and related benefits for employees laid off under the reduction in force, consisting primarily of severance payments and continued healthcare benefits for a specific period of time.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1851194/000119312523290726/0001193125-23-290726-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.